Agenus (AGEN) Total Current Liabilities (2010 - 2026)
Agenus (AGEN) posted quarterly Total Current Liabilities of $249.2 million for Q1 2026, up 19.65% year-over-year from $208.3 million in Q1 2025, and down 22.95% quarter-over-quarter from $323.5 million in Q4 2025.
Agenus (AGEN) Total Current Liabilities (2010 - 2026) Analysis & Trends
Agenus' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $249.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 19.65% year-over-year to $249.2 million; the TTM figure through Mar 2026 stood at $249.2 million (up 19.65% YoY), while the FY2025 annual figure was $323.5 million, up 46.11% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $249.2 million, down from $323.5 million in the prior quarter.
- The five-year high for Total Current Liabilities was $323.5 million in Q4 2025, with the low at $645000.0 in Q3 2025.
- The 5-year median for Total Current Liabilities is $190.9 million (2023), against an average of $157.9 million.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 7922.11% in 2024, then slumped 98.85% in 2025.
- Agenus' Total Current Liabilities stood at $3.5 million in 2022, then soared by 7200.91% to $255.9 million in 2023, then dropped by 13.48% to $221.4 million in 2024, then soared by 46.11% to $323.5 million in 2025, then declined by 22.95% to $249.2 million in 2026.
- Business Quant data shows AGEN's Total Current Liabilities at $249.2 million in Q1 2026, $323.5 million in Q4 2025, and $645000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | 231.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 231.82 Mn |
| Mar 31, 2026 | 249.24 Mn |
| Dec 31, 2025 | 323.49 Mn |
| Sep 30, 2025 | 645,000.00 |
| Jun 30, 2025 | 3.13 Mn |
| Mar 31, 2025 | 208.30 Mn |
| Dec 31, 2024 | 221.40 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 270.67 Mn |
| Mar 31, 2024 | 256.00 Mn |
| Dec 31, 2023 | 255.90 Mn |
| Sep 30, 2023 | 198.36 Mn |
| Jun 30, 2023 | 3.37 Mn |
| Mar 31, 2023 | 190.90 Mn |
| Dec 31, 2022 | 3.51 Mn |
| Sep 30, 2022 | 173.07 Mn |
| Jun 30, 2022 | 159.72 Mn |
| Mar 31, 2022 | 163.06 Mn |
| Dec 31, 2021 | 156.94 Mn |
| Sep 30, 2021 | 150.13 Mn |